2019
DOI: 10.1016/j.jacc.2018.10.070
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Events After Deferral of LAD Revascularization Following Physiological Coronary Assessment

Abstract: BackgroundPhysicians are not always comfortable deferring treatment of a stenosis in the left anterior descending (LAD) artery because of the perception that there is a high risk of major adverse cardiac events (MACE). The authors describe, using the DEFINE-FLAIR (Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation) trial, MACE rates when LAD lesions are deferred, guided by physiological assessment using fractional flow reserve (FFR) or the instantaneous wave-free ratio (iFR).Objec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 37 publications
(21 citation statements)
references
References 16 publications
0
21
0
Order By: Relevance
“…A study by Sen et al showed that in LAD lesions, iFR-guided deferral is safer than FFR-guided deferral and significantly lower MACE rates. 15 However, our study was only with FFR, not in comparison with other functional modalities of assessment.…”
Section: Discussionmentioning
confidence: 99%
“…A study by Sen et al showed that in LAD lesions, iFR-guided deferral is safer than FFR-guided deferral and significantly lower MACE rates. 15 However, our study was only with FFR, not in comparison with other functional modalities of assessment.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, post-hoc analysis of the pooled population of the DEFINE-FLAIR and iFR-SWEDEHEART trials 25 and post-hoc analysis of the DEFINE-FLAIR trial 26 suggested the possible superiority of iFR-guidance in deferral of LAD lesions or patients with acute coronary syndrome, based on higher risk of MACE after FFRguidance in these patient subsets. However, none of those post-hoc analyses had enough study power to validate the differences among subgroups.…”
Section: Clinical Outcomes Of Discordance Between Ifr and Other Restimentioning
confidence: 99%
“…8 The insights from this study suggest one explanation of the results of the DEFINE-FLAIR LAD sub-analysis, which demonstrated superior clinical outcomes among patients deferred with iFR in the LAD compared to FFR. 9 The rate the composite of cardiovascular death, myocar-logically diffuse and 81.5% (123/151) physiologically focal.…”
Section: Ffr/ifr Discordance In the Non-ladmentioning
confidence: 99%